-
Carbapenemase Gene Transfer in Enterobacter cloacae
2026-09-15
This 2025 multicenter study mapped carbapenemase-encoding genes, their chromosomal or plasmid locations, transferability, and strain relatedness in carbapenem-resistant Enterobacter cloacae from eight Guangdong teaching hospitals. Its integrated approach shows that blaNDM-1 was common, frequently plasmid-associated, and readily transferable, providing a practical framework for interpreting resistance surveillance and transmission risk.
-
5-hme-dCTP for Plant 5hmC Workflows
2026-09-15
Use 5-hme-dCTP as a controlled DNA polymerase substrate for hydroxymethylation assay development, synthetic controls, and plant epigenetic studies. The workflow connects reagent-level precision with rice drought-response findings while separating practical assay recommendations from published evidence.
-
TAK1–YAP Control of Gastric Cancer Stem Cells
2026-09-14
This study identifies TGFβ-activated kinase 1 (TAK1) as an IL-6-responsive regulator that stabilizes yes-associated protein (YAP) and sustains gastric cancer stem-cell self-renewal. Its integrated tissue, cellular, molecular, and in vivo experiments connect TAK1–YAP signaling with SOX2/SOX9 transcription and gastric tumorigenesis, while also defining limits for translating these findings into chemotherapy workflows.
-
WAY-100635 Workflows for 5-HT1A Pain Research
2026-09-14
WAY-100635 enables receptor-specific tests of whether serotonergic signaling contributes to pain, affect, and neuronal activity. This workflow connects receptor binding and functional assays with formalin/CFA behavioral models while highlighting controls for solubility, timing, and interpretation.
-
Protease Inhibitor Cocktail for Plant Extracts
2026-09-13
Protect fragile plant proteins from rapid post-lysis degradation with a broad-spectrum, EDTA-free formulation designed for downstream immunoblotting, pull-down, imaging, and kinase workflows. This guide connects practical extract handling with mutation-focused assay design, helping distinguish genuine biology from sample damage.
-
DAPI Workflows for iMSC Exosome Assays
2026-09-12
Use DAPI to connect nuclear morphology, membrane integrity, and cell-count quality control in iMSC-exosome studies of nucleus pulposus degeneration. This practical workflow separates fixed-cell imaging from live-cell viability and flow cytometry DNA staining, helping researchers avoid interpreting nuclear fluorescence as a standalone apoptosis or mechanism readout.
-
Eltanexor (KPT-8602) Workflow for XPO1 Studies
2026-09-12
Eltanexor (KPT-8602) enables practical studies of XPO1-dependent nuclear export in leukemia, lymphoma, and colorectal cancer models. This workflow connects dose-response testing with localization, Wnt/β-catenin, organoid, and in vivo readouts while highlighting formulation and assay-design decisions that improve reproducibility.
-
Oral Microgel Nanotherapy for Local Colon Cancer
2026-09-11
The reference study develops a sequentially targeted oral platform in which cisplatin/SPION lipid nanoparticles are protected by dextran microgels and released in the colon. In orthotopic colon cancer-bearing mice, the system combined localized chemotherapy with alternating-magnetic-field-induced heating to reduce tumor growth and peritoneal carcinomatosis while addressing key barriers to oral nanomedicine.
-
G007-LK Tankyrase 1/2 Inhibitor: Practical Guide
2026-09-11
G007-LK connects tankyrase target engagement with Wnt/β-catenin, Hippo/YAP, and cancer-cell phenotypes in practical assay workflows. This guide covers formulation, dose-response design, pathway confirmation, comparative use cases, and troubleshooting for colorectal and hepatocellular carcinoma models.
-
25-Hydroxycholesterol Reprograms Immunosuppressive TAMs
2026-09-10
Xiao et al. identify CH25H and lysosomal 25-hydroxycholesterol as an immunometabolic checkpoint that connects cholesterol handling to AMPKα–STAT6 signaling in tumor-associated macrophages. The study shows that disrupting this axis increases T-cell activity and can enhance anti-PD-1 responses in preclinical tumor models.
-
BCECF for Extracellular pH Assays
2026-09-10
BCECF converts extracellular acid–base changes into a quantitative dual-excitation signal, making it useful for ion transport, metabolic flux, and immune microenvironment studies. This workflow shows how to pair pH mapping with macrophage efferocytosis experiments inspired by recent neuropathic pain research—while clearly separating established findings from hypothesis-generating applications.
-
Sulforaphane: From Redox Biology to Translation
2026-09-09
A mechanism-led perspective on Sulforaphane that connects Keap1–Nrf2 signaling, oxidative stress, NLRP3 inflammasome activity, G2/M arrest, apoptosis, and translational assay strategy.
-
HABA Assays for Avidin-Biotin Research
2026-09-09
HABA converts avidin and streptavidin binding events into a practical absorbance readout for biotin quantification, surface-accessibility testing, and bioconjugate quality control. Its strongest value emerges when paired with particulate delivery workflows, where it can distinguish total ligand loading from functionally exposed binding sites.
-
Tetrahydromagnolol CB2 Assay Workflows
2026-09-08
Tetrahydromagnolol combines potent peripheral CB2 agonism with measurable GPR55 antagonism, enabling more discriminating cannabinoid receptor research than a single-pathway probe. This guide translates that pharmacology into receptor, signaling, migration, and inflammation-focused workflows informed by a GPCR–cytoskeleton study in triple-negative breast cancer.
-
Isradipine (Dynacirc) Research Workflows
2026-09-08
Isradipine (Dynacirc) provides a practical L-type calcium-channel perturbation for separating vascular smooth muscle responses from neuronal calcium dysregulation. This guide combines formulation guidance, electrophysiology, excitotoxicity assays, hypertension research, troubleshooting, and reference-backed interpretation.